US Tech 100

18,563.60

-0.16%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
USOTC
Anthera Pharmaceuticals Inc (CE) (ANTH)
Anthera Pharmaceuticals Inc (CE) (ANTH) News

ANTH

Anthera Pharmaceuticals (CE) (ANTH)

Anthera Pharmaceuticals Inc (CE)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ANTH

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
09/12/2018	3:21PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/30/2018	4:45PM	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/27/2018	6:02AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/27/2018	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/27/2018	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/27/2018	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/27/2018	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/27/2018	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/27/2018	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:28PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:28PM	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:28PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:27PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:27PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:27PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:27PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:27PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:26PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:24PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:24PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:23PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:23PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:22PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:21PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/20/2018	4:06PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/17/2018	2:38PM	Edgar (US Regulatory)	(25)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/09/2018	5:08PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
06/27/2018	4:14PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
06/27/2018	8:00AM	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the...	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
06/18/2018	4:32PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)